Hero Image Hero Mobile Image

Support and resources are
available to you and your patients

  • Prescribing FILSUVEZ
  • Chiesi Total Care
  • FILSUVEZ Friends
  • Patient resources
Prescribing FILSUVEZ

Getting your patient started with FILSUVEZ is simple

2
Once you have completed the forms:
1. Attach copies of patient insurance and prescription cards – front and back.
2. First prescription for the patient:
THE FIRST COPY OF THE FORM MUST BE FAXED FOR EACH PATIENT. Fax completed form to Chiesi Total Care at 1-877-914-0591. PLEASE COMPLETE ONE FORM PER PATIENT.
3. Subsequent prescriptions:

After the initial script is filled, future prescriptions can be made via telephone or e-script. If you wish to send additional forms via e-script please search for "PANTHERx" in your EMR/HMR’s e-prescribing software.

Chiesi Total Care
For your patient to be eligible, you must first submit a prescription for FILSUVEZ to the specialty pharmacy

Chiesi Total CareSM simplifies access and support so your focus can be on progress

Chiesi Total Care helps families start FILSUVEZ, streamlines access, and provides ongoing support throughout the FILSUVEZ treatment journey.
logo-chiesi-total-care logo-chiesi-total-care
Learn more at 1-833-670-6464,
Monday through Friday, AM to 8 PM ET.

The Chiesi Total Care Program assists with:

icon-1 icon-1-mobile
Insurance Consultation and Financial Support*†
icon-2 icon-2-mobile
Treatment Support & Logistics Coordination
icon-3 icon-3-mobile
Nursing Support & Personalized Education
icon-4 icon-4-mobile
Dedicated Total Care Team
Zero-Copay
Eligible patients may pay
as little as a $0 copay
*Patients participating in a government healthcare plan are not eligible for financial assistance programs.
Please refer to the full Terms and Conditions for eligibility requirements.

See what Chiesi Total Care has to offer

Get your patient started
FILSUVEZ Friends

One-on-one support from a FILSUVEZ Friends patient or caregiver

Living with DEB or JEB can feel isolating for both patients and caregivers. FILSUVEZ Friends was created to support patients who are considering or have not yet started treatment, as well as their caregivers, by providing encouragement and helping them build meaningful connections as they navigate life with EB and FILSUVEZ treatment.
CHIE_FILS_FriendsLogo_Color@2x 1
See how your patient can get involved in FILSUVEZ Friends
Learn more
Participants must be at least 18 years of age or accompanied by a parent or guardian and reside in the United States. FILSUVEZ Friends patients and caregivers do not provide medical advice and only share their personal experiences. Conversations are not meant to take the place of discussions with healthcare providers.
Patient resources
Watch a wound care-certified nurse from the specialty pharmacy explain what you and your patients should know about treatment with FILSUVEZ
swipe-note Swipe to see content
Learn more about Henry's real experience using FILSUVEZ
how-to-use brochure
Provide your patients with helpful tips for applying FILSUVEZ
Download How to Use Brochure
consideration brochure
Help your patients learn how FILSUVEZ can benefit them
Download Consideration Brochure
Monarch brochure
Share The Monarch to empower your pediatric patients
Download The Monarch
Subscribe to receive the latest updates on FILSUVEZ
Request more information

Important Safety Information & Indication

Important Safety Information

Warnings & Precautions

Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.

Adverse Reactions

The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).

Patient Counseling Information

Please refer to Prescribing Information for administration instructions.

To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see Full Prescribing Information.

Indication

FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

Important Safety Information & Indication

Important Safety Information

Warnings & Precautions

Local hypersensitivity and skin reactions have been reported in patients treated with FILSUVEZ, including urticaria and dermatitis. If signs or symptoms of hypersensitivity occur, discontinue use immediately and initiate appropriate therapy.

Adverse Reactions

The most commonly reported adverse reaction in clinical trials was pruritus and pain at the wound application site (7.3%).

Patient Counseling Information

Please refer to Prescribing Information for administration instructions.

To report SUSPECTED ADVERSE REACTIONS, contact Chiesi USA Inc. at 1-888-661-9260 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see Full Prescribing Information.

Indication

FILSUVEZ is indicated for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.

PP-RA-01348 V1.0